New cream aims to calm cancer drug skin side effects
NCT ID NCT04731259
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 33 times
Summary
This study tested a cream called ATR-04 to see if it could safely reduce the facial rash that often happens with certain cancer drugs (EGFR inhibitors). About 60 people with cancer who were about to start these drugs would have used the cream twice daily for 28 days. The study was withdrawn before any participants enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMAL GROWTH FACTOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.